China Dominates APAC’s Emergence As Global Trials Hub

39% Of Total Trial Starts In ’23

 
• By Ian Haydock
  
APAC
China dominates APAC clinical trials activity • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Global Vision

More from Market Intelligence